The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. (Q44164808)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2002
edit
Language Label Description Also known as
English
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
scientific article published in October 2002

    Statements

    title
    The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed publication ID
    12359989
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12359989%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    13 December 2019

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q44164808&oldid=2137978023"